Conditions: Bacterial Conjunctivitis
Keywords: Ocular infections, bacterial
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 33
Healthy volunteers: no

Brief summary:
The objective of this study is to evaluate the safety and efficacy of Besivance (besifloxacin 0.6%) ophthalmic suspension compared to gatifloxacin 0.3% ophthalmic solution when administered three times daily (TID) for seven days to neonatal subjects who are 31 days or younger on the day of randomization (Visit 1).

Detailed description:

Arms:
arm 1: Besifloxacin 0.6% ophthalmic suspension arm 2: Gatifloxacin 0.3% ophthalmic solution

Interventions: intervention 1: Besivance intervention 2: Gatifloxacin
Intervention descriptions: intervention 1: Besifloxacin hydrochloride 0.6% ophthalmic suspension, one drop instilled into infected eye, three times daily (TID) for 7 days intervention 2: Gatifloxacin 0.3% ophthalmic solution one drop instilled into infected eye, TID for 7 days

Protocol document: